Capricorn Fund Managers’s Palvella Therapeutics PVLA Stock Holding History

Capricorn Fund Managers’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.15M	Buy	+14,088	New	+$1.71M	0.17%	112

Other funds holding PVLA

Clio Asset Management Charlottesville, Virginia $126M AUM 16.01% 1-Year Est. Return

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Capricorn Fund Managers's PVLA Position: Q2 2026 in Review

Capricorn Fund Managers opened a new position in Palvella Therapeutics (PVLA) in Q2 2026: 14,088 shares worth $2.15M. The stake represents 0.17% of the portfolio and ranks #112 among its holdings.

18 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

Capricorn Fund Managers held 14,088 shares of Palvella Therapeutics worth $2.15M as of Q2 2026.
Palvella Therapeutics was a new Capricorn Fund Managers position in Q2 2026.
Palvella Therapeutics made up 0.17% of Capricorn Fund Managers's portfolio in Q2 2026, its #112 holding.
18 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.